Literature DB >> 30790395

Gastrodin attenuates neuroinflammation in DOI-induce Tourette syndrome in rats.

Hongyan Long1, Chunyan Wang2, Jie Ruan1, Mengjiao Zhang2, Yaruo Huang2.   

Abstract

OBJECTIVE: Tourette syndrome (TS) is a chronic neuropsychiatric disorder. Its clinical manifestations are involuntary and recurrent muscle twitch, resulting in motor twitch and occurrence twitch. Traditional Chinese medicine has obvious advantages in treating TS. The aim of this study was to investigate the effects and mechanism of gastrodin on 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced TS in rats.
METHODS: TS model was induced by DOI. Behaviors in TS rats were detected. The striatum, serum inflammatory factors interleukin-6, interleukin-1β, and tumor necrosis factor-a were detected by enzyme-linked immunosorbent assay. Western blot technique was used to detect the expressions of TLR/NF-κB and TLR/MAPK signaling pathways in the striatum.
RESULTS: Gastrodin can significantly improve behavioral changes of TS rats induced by DOI, reduce inflammatory factors in serum and striatum in TS rats, and inhibit activation of TLR/NF-κB and TLR/MAPK signaling in striatum in TS rats.
CONCLUSION: Gastrodin can significantly relieve the TS induced by DOI in rats. Its mechanism is related to the inhibition of striatal TLR/NF-κB and TLR/MAPK signaling activation.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Tourette syndrome; gastrodin; inflammation

Mesh:

Substances:

Year:  2019        PMID: 30790395     DOI: 10.1002/jbt.22302

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  4 in total

1.  Gastrodin Attenuates Tourette Syndrome by Regulating EAATs and NMDA Receptors in the Striatum of Rats.

Authors:  Xueran Sun; Xin Zhang; Keyu Jiang; Min Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-12       Impact factor: 2.570

2.  Gastrodin relieves inflammation injury induced by lipopolysaccharides in MRC-5 cells by up-regulation of miR-103.

Authors:  Zhuona Xi; Yahong Qiao; Jifang Wang; Hongjian Su; Zhen Bao; Hongyan Li; Xiaoming Liao; Xiaolan Zhong
Journal:  J Cell Mol Med       Date:  2019-11-25       Impact factor: 5.310

3.  Neuroinflammation in a Rat Model of Tourette Syndrome.

Authors:  Ke Zhongling; Chen Yanhui; Chen Guofeng; Liu Yanyan
Journal:  Front Behav Neurosci       Date:  2022-03-10       Impact factor: 3.558

4.  Jing-an oral liquid alleviates Tourette syndrome via the NMDAR/MAPK/CREB pathway in vivo and in vitro.

Authors:  Leying Xi; Xixi Ji; Wenxiu Ji; Yue'e Yang; Yajie Zhang; Hongyan Long
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.